Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow the company to bring leading innovative products to the Canadian market. Tune in!

Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris’ Corner
Latest Articles
- Brazil Potash (GRO.NYSE) bets big on domestic supply as global potash politics simmer
- Emerita Resources (EMO.V) legal battle may be set to pay off this month
- Highballer Report: Gold’s big run and the juniors benefitting
- Prospera Energy (PEI.V) with no money to pay creditors, buys chairman Shubham Garg’s debt
- Highballer Roundup: Goliath Resources, Amarc Resources, Radisson Mining, Collective Mining and more
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments lithium Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources shrooms stock market stocks technology trading uranium wealth wealth creation weed
Leave a Reply